Certara Inc
CERT
Get informed when a big investor buys or sells
+ FollowMarket Cap$905.39M
Close$
$8.54
52.5% upside
Current Fair Value
52.5% upsideUndervalued by 52.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $905.39 Million |
|---|---|
| Enterprise Value | $843.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.54 |
| Outstanding Shares | 157,754,647 |
Return
| Return on Equity | -1.48% |
|---|---|
| Return on Assets | -1.01% |
| Return on Invested Capital | 3.04% |
Valuation & Multiples
| P/E Ratio | -60.8 |
|---|---|
| PEG | 21.35 |
| Price to Sales | 2.8 |
| Price to Book Ratio | 0.93 |
| Enterprise Value to Revenue | 2.01 |
| Enterprise Value to EBIT | 20.48 |
| Enterprise Value to Net Income | -56 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$106.13 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$0.10
Average shareholder expectationRevenue Estimate
$98.57 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0289▲ 2.89% |
|---|---|
| Total Calls | 393,800▲ 553.07% |
| Total Puts | 11,400▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 83.99%▼ 7.86% |
|---|---|
| Total Invested | $768.47M▼ 40.81% |
| Investors Holding | 2560% |
ESG Score
No data
About Certara Inc
300 employeesCertara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the ...